In last trading session, Summit Therapeutics Inc (NASDAQ:SMMT) saw 3.21 million shares changing hands with its beta currently measuring -0.96. Company’s recent per share price
In last trading session, Summit Therapeutics Inc (NASDAQ:SMMT) saw 4.67 million shares changing hands with its beta currently measuring -0.96. Company’s recent per share price
Summit Therapeutics Inc (NASDAQ:SMMT) has a beta value of -0.95 and has seen 2.32 million shares traded in the last trading session. The company, currently
During the last session, Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares were 1.69 million, with the beta value of the company hitting -0.95. At the end
In the last trading session, 3.14 million shares of the Summit Therapeutics Inc (NASDAQ:SMMT) were traded, and its beta was -0.94. Most recently the company’s
In the last trading session, 9.37 million shares of the Summit Therapeutics Inc (NASDAQ:SMMT) were traded, and its beta was -0.92. Most recently the company’s
Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares stood at 2.9 million during the last session, with the company’s beta value hitting -0.93. At the close of
Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares stood at 4.73 million during the last session, with the company’s beta value hitting -0.93. At the close of
In the last trading session, 5.65 million Summit Therapeutics Inc (NASDAQ:SMMT) shares changed hands as the company’s beta touched -0.98. With the company’s per share
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
